Immunic Inc. buy Piper Sandler
Start price
17.07.24
/
50%
€1.33
Target price
17.07.25
€25.68
Performance (%)
-41.20%
End price
18.07.25
€0.78
Summary
This prediction ended on 18.07.25 with a price of €0.78. Massive losses of -41.20% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunic Inc. | -6.620% | -6.620% | -43.579% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by Piper_Sandler for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $28.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat
In the thread Trading Immunic Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten